Alebund Pharmaceuticals and R1 Therapeutics Partner to Advance Novel Hyperphosphatemia Treatment SHANGHAI, March 17, 2026 – Alebund Pharmaceuticals, a renal-focused biopharmaceutical company, has entered into licensing and equity agreements with …
Tag: